Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy.

Capsaicin is under clinical development by Grunenthal and currently in Phase III for Chemotherapy Induced Peripheral Neuropathy.

blocker approved for the treatment of chronic inflammatory demyelinating polyneuropathy or CIDP. CIDP is a progressive, immune-mediated rare and debilitating neuromuscular disorder of the peripheral ...

According to the results of a new study, “cannabis-based medicines may be effective in treating the pain and symptoms of ...

Having cold feet and hands during winter is pretty common. While temperature is one of the factors, it is not the only one.